ACCRETROPIN

LOE Approaching

somatropin

BLAINJECTIONINJECTABLE
Approved
Jan 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

cells. This interaction results in intracellular signal transduction and subsequent induction of transcription and translation of GH-dependent proteins including IGF-1, IGF BP-3 and acid-labile subunit. Somatropin has direct tissue and metabolic effects or effects mediated indirectly by IGF-1,…

Clinical Trials (5)

NCT07221851Phase 3Recruiting

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

Started Dec 2025
186 enrolled
Turner SyndromeShort Stature Homeobox Gene MutationIdiopathic Short Stature+1 more
NCT06433557Phase 2Active Not Recruiting

A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia

Started Jul 2024
22 enrolled
Achondroplasia
NCT05775523N/ARecruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Started Mar 2023
500 enrolled
Growth Hormone Deficiency
NCT05690386Phase 2Active Not Recruiting

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

Started Feb 2023
48 enrolled
Turner Syndrome
NCT05171855Phase 3Completed

A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency

Started Dec 2021
220 enrolled
Adult Growth Hormone DeficiencyEndocrine System DiseasesHormone Deficiency